Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProtoLytic is a private healthcare technology company that develops AI-enabled decision-support and workflow software for medical claims processing, utilization review, and payment integrity. Its products are designed primarily for insurers, case managers, and related healthcare administrative users rather than for drug discovery or therapeutic development. The company\u2019s flagship offerings include Proto-Link, an API and rules engine that applies CMS, state reimbursement, and treatment rules, and UR Express, a cloud-based utilization review and medical case management platform. ProtoLytic appears focused on automating complex claims adjudication and evidence-based review workflows across U.S. jurisdictions. The business is health-related, but it is not a biotech or pharma drug developer and does not appear to maintain a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProtoLytic.